Position in NNVC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$734
-$29,726 QoQ
Shares Held
532
-98.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 48 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NNVC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Integrated Wealth Concepts LLC holds $51,203,908 across 302 Biotechnology names. NNVC ranks #257 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
152,216 | $8,709,799 | |
| 2 | INVA |
Innoviva, Inc.
|
350,575 | $7,961,558 | |
| 3 | EXEL |
Exelixis, Inc.
|
69,926 | $3,804,673 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,994 | $3,474,129 | |
| 5 | DNLI |
Denali Therapeutics Inc.
|
102,241 | $2,629,638 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,692 | $2,014,492 | |
| 7 | INCY |
Incyte Corp
|
17,318 | $1,963,168 | |
| 8 | TLX |
Telix Pharmaceuticals Ltd
|
164,397 | $1,895,497 |
All Filings in NNVC
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $734 | 532 | Shares | Sole | 2026-08-12 | |
| 2025-03-31 | $30,460 | 26,035 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $54,390 | 38,035 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $80,002 | 53,335 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $63,356 | 36,835 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||